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Abstract Although a number of nucleoside diphosphate kinases 
(NDPKs) have been reported to act as inhibitors of metastasis or 
as a transcription factor in mammals, it is not known whether 
these functions are linked to their enzymatic activity or how this 
protein is regulated. In this report, we show that in vitro protein 
kinase CK2 catalyzed phosphorylation of human NDPK A 
inhibits its enzymatic activity by inhibiting the fust step of its 
ping-pong mechanism of catalysis: its autophosphorylation. 
Upon in vlvo 32P labeling of HeLa cells, we observed that both 
human NDPKs, A and B, were autophosphorylated on histidine 
residues, however, only the B isoform appeared to be serine 
phosphorylated. 
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1. Introduction 
Nucleoside diphosphate kinase (NDPK) (EC 2.7.4.6) is a 
ubiquitous enzyme that catalyzes the transfer of a terminal 
phosphate from oxy- or deoxy-NTPs to oxy- or deoxy- 




where NiTP is physiologically ATP [l]. In the first step of the 
reaction, the enzyme is phosphorylated in an N6 position of a 
strictly conserved histidine of the active site [2]; this inter- 
mediate of the reaction is stable in the absence of an acceptor 
N2DP. 
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Abbreviations: NDPK, nucleoside diphosphate kinase; CK2, protein 
kinase CK2 (formerly called casein kinase 2); DMEM, Dulbecco’s 
modified Eagle’s medium. 
The NDPKs crystallized so far have been found to be hex- 
amers [3-51, with the exception of the Myxococcus xanthus 
enzyme which has a tetrameric structure [6]. In lower eukar- 
yotes, the enzyme is composed of six identical subunits 
whereas in vertebrates and plants at least two different sub- 
units have been found [1,7]. Human NDPK is a hexamer 
composed variably of two different subunits (A and B) which 
share 88% identity, exhibit different pZ values and electro- 
phoretic mobilities [8] and have a different intracellular loca- 
lization; while the two isoforms are found in the cytoplasm, 
only NDPK B has been described as having a nuclear locali- 
zation [9]. 
The classical role ascribed to the NDPKs has been to main- 
tain the intracellular NTPs pool [l]. More recently, human 
NDPK A and murine NDPKs a and j3 (encoded by nm23- 
Hl, nm23-Ml and nm23-M2, respectively) have been charac- 
terized as inhibitors of metastasis [IO-121. Also, human 
NDPK B has been identified as ‘PuF’, a factor that stimulates 
transcription of the proto-oncogen c-myc [13,14]. However, at 
present, it is not clear how these processes are regulated. 
An important autophosphorylation on serine residues was 
claimed to occur in several NDPKs [15-171, and it was sug- 
gested that serine phosphorylation could correlate with the 
inhibition of metastasis [16]. Nevertheless, the importance of 
serine autophosphorylation is in doubt since results obtained 
using methodologies that unambiguously recognize non-histi- 
dine phosphorylation, as shown by Bominaar et al. [18] and 
by us [19], clearly demonstrated that autophosphorylation on 
serine residues could only account for less than 0.2% of the 
total autophosphorylation. 
We have previously shown that NDPKs from different ori- 
gins are in vitro substrates of recombinant human protein 
kinase CK2 (rhCK2) [20], however, the potential action of 
this phosphorylation on enzymatic activity was not investi- 
gated. In the present work, we used recombinant human 
NDPK A (rhNDPK A) as the main model for studying the 
effect of phosphorylation by rhCK2 on enzyme activity. We 
present evidence that phosphorylation of the enzyme by CK2 
inhibits its overall enzymatic activity by inhibiting the first 
step of the reaction, i.e. autophosphorylation. To reinforce 
the idea that phosphorylation by CK2 could represent a reg- 
ulatory mechanism of NDPK activity we investigated whether 
NDPKs from HeLa cells could be phosphorylated in vivo on 
serine residues. 
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2. Materials and methods 
2.1. Materials 
Recombinant human protein kinase CK2, and NDPK A were pre- 
pared as described [20,21]. RhNDPK B was obtained according to 
[22]. [y-32P]ATP was obtained from New England Nuclear; carrier- 
free [32P]orthophosphate was obtained from the Comisidn National 
de Energia Atomica, Buenos Aires, Argentina. Protein A-Sepharose 
and okadaic acid were from Sigma. Polyacrylamide gel electrophoresis 
reagents were from Bio-Rad. X-ray films (Curix-RPl) were from Agfa 
Gevaert. Immobilon-P transfer membranes were from Millipore. All 
other reagents were of analytical grade. 
2.2. In vitro phosphorylation of recombinant human NDPK A by CK2 
RhNDPK A was phosphorylated essentially as described in [20] 
except that, in experiments aimed to measure enzymatic activity or 
autophosphorylation of NDPK, CK2 catalyzed phosphorylation was 
performed with unlabeled ATP. A control in which rhCK2 was not 
added was performed in parallel. At the times indicated, aliquots were 
taken from the incubated CK2 and control tubes, the reaction was 
stopped by the addition of 40 &ml heparin and the samples were 
kept on ice until processing. 
2.3. Assay of NDPK activity 
Enzymatic activity was assessed by incubating the samples for 10 
min at 30°C as described [23] using pyruvate kinase as a coupled 
enzyme and measuring the pyruvic acid formed using the 2,4-dinitro- 
phenylhydrazone method [24]. Briefly, the standard incubation mix- 
ture contained 50 mM Tris-HCl, pH 7.5, 2 mM ATP, 2 mM dTDP, 
5 mM MgClz, 60 mM KCI, 0.2 units of pyruvate kinase and an 
appropriate dilution of the enzyme (made in BSA buffer containing: 
50 mM Tris-HCl pH 7.5, 0.5 mg/ml BSA) in a final volume of 0.1 ml. 
1 unit of NDPK activity was defined as the amount of enzyme that 
catalyzed the transfer of 1 umol of phosphate from ATP to dTDP per 
min under these conditions. 
2.4. Assay of NDPK autophosphorylation 
Autophosphorylation assays were performed at 4°C in a reaction 
mixture containing 50 mM Tris-HCl, pH 7.5, 0.5 mM MgClz, 10 mM 
EDTA, 100 FM [y-32P]ATP (10 mCi/umol) and an appropriate dilu- 
tion of the enzyme (made in BSA buffer) in a final volume of 10 11. 
After 10 min incubation, the reaction was stopped with 1 vol. of 
2 x Laemmli sample buffer [25], and heated for 2 min at 45°C. The 
products were separated by 15% SDS-PAGE according to Laemmli 
[25] and visualized by autoradiography of the dried gels after over- 
night exposure. 
2.5. Metabolic labeling of cultured HeLa cells and immunoprecipitation 
of NDPKs 
HeLa cells were maintained as described by Rosenblatt et al. [26]. 
For experimental purposes, cells were plated into 60 mm Petri dishes 
in Dulbecco’s modified Eagle’s medium supplemented with low mo- 
lecular weight nutrients and 5% fetal calf serum. 2 days later, the 
cultures received fresh medium containing only 100 uM phosphate 
and 5% dialyzed fetal calf serum. Under such conditions, HeLa cells 
exhibit continuous division. For NDPK phosphorylation studies, cells 
were incubated with 300 pCi of carrier-free [32P]orthophosphate 3 h 
prior to stimulation to allow steady-state labeling of the endogenous 
ATP pool. The culture was then stimulated for 2 h with 10% dialyzed 
fetal calf serum. Okadaic acid (1 PM) was added to the culture me- 
dium for the last 15 min. Cells were then rinsed twice in a solution 
containing 20 mM Tris-HCl, pH 7.5 and 0.15 M NaCl, at 4’C; the 
extracts were prepared with the addition of a chilled solution contain- 
ing 10 mM Tris-HCl, pH 7.6, 5 mM NaF, 100 pM orthovanadate, 
1 mM PMSF, and 1% Nonidet P40. Cell extracts were centrifuged at 
10000 rpm for 30 min in a refrigerated microcentrifuge. The super- 
natant was used immediately for immunoprecipitation of NDPKs as 
described [19] except that the antibodies used were a mixture of 4 dif- 
ferent monoclonal anti-NDPK antibodies to ensure immunoprecipita- 
tion of both NDPK isotypes. The antibodies used were mAb 37.6, 
10-2, and 126-1, which recognize native and denatured A and B sub- 
units with high affinity, and mAb 143-2, which recognizes the qua- 
ternary conformation of NDPKs from different origins. The incuba- 
tion time was 1 h. 
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2.6. Evaluation of acid and base stability of in viva phosphorylated 
NDPKs on Immobilon membranes 
The methodology used was as described [19], employing 3 h incu- 
bations in the different pH buffers. Under these conditions, phosphate 
bound to histidine residues is depleted during incubation at pH 1, 
while that bound to serine/threonine remains. In contrast, incubation 
at pH 14 depletes phosphates bound to serine/threonine residues while 
histidine phosphorylation is stable under these conditions. 
3. Results and discussion 
3.1. Effect of rhCK2 phosphorylation on rhNDPK enzymatic 
activity and autophosphorylation 
To investigate whether in vitro phosphorylation by CK2 
produces any change in NDPK enzymatic activity, it was im- 
portant to ensure a high degree of phosphorylation of NDPK. 
Previous studies indicated that, among the NDPKs which 
served as substrates for CK2, NDPK A was the most effi- 
ciently phosphorylated, being a 2.5-times better substrate 
than the B counterpart [20]. A time course experiment was 
performed as detailed under Section 2 using rhNDPK A as 
substrate. Aliquots obtained from CK2 incubated (+CK2) 
and from controls devoid of CK2 (-CK2) were diluted and 
tested for NDPK activity (Fig. 1A). As can be seen, time- 
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Fig. 1. Activity and autophosphorylation of rhNDPK A as a func- 
tion of phosphorylation by rhCK2. RhNDPK A was phosphory- 
lated in a time course experiment (H, +CK2) or incubated in the 
reaction mixture in the absence of CK2 as control (0-0, -CK2) 
as described under Section 2. (A) Remnant NDPK activity of 
rhCK2-phosphorylated rhNDPK A. Aliquots of rhNDPK A with 
different extents of phosphorylation (o-+) and controls not phos- 
phorylated (0-o) were diluted (more than 2000-fold) and tested 
for NDPK activity. All activities are referred to zero time taken as 
100% (300 units/mg at 30°C). Error bars indicate the standard de- 
viation from three different dilutions from the original sample. (B) 
Autophosphorylation of CK2 phosphorylated rhNDPK A. Equal 
amounts of rhNDPK A from CK2 treated samples with different 
extents of phosphorylation (+CK2) or control experiments (-CK2) 
were taken at the times indicated and assessed for autophosphoryla- 
tion as described in Section 2. The arrow indicates the position of 
rhNDPK A. 
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Fig. 2. In vivo phosphorylation of NDPKs. Acid and base stable 
phosphorylation of in vivo labeled NDPKs. NDPKs were irnmuno- 
precipitated from crude extracts of HeLa cells labeled in vivo with 
32P as described in Section 2. Protein A-Sepharose-bound NDPK 
immunocomplexes were resuspended in sample buffer directly or 
after incubation in buffer containing 10 mM Mg2+.TDP (5 min at 
room temperature), separated by SDS-PAGE and transferred to Im- 
mobilon membranes. The sample incubated with Mg’+.TDP (lane 1) 
had approx. 15 times more protein loaded than the other lanes 
(which have exactly the same amount). Immobilon stripes were 
either incubated at pH 14 (lane 4), pH 1 (lane 3) or not treated 
(lane 2) in order to determine the type of phosphorylated residue 
present in immunoprecipitated NDPK. A and B indicate the posi- 
tions of autophosphorylated NDPKs A and B, respectively; C de- 
notes the position of serine phosphorylated NDPK. The labeled 
bands of higher molecular mass probably represent dimers or tri- 
mers of NDPK, resulting from incomplete denaturation and/or di- 
sulfide cross-linking. 
dependent inactivation of NDPK occurs in samples preincu- 
bated with CK2 compared with controls devoid of CK2. 
Maximal inhibition, around 80%, was achieved after 2 h in- 
cubation with CK2. In phosphorylation experiments per- 
formed in parallel using [y-32P]ATP, the maximum CK2-cat- 
alyzed phosphorylation of rhNDPK A attained was approx. 
0.8 mol phosphate per mol of monomer after 2 h incubation 
(not shown). When rhNDPK B was used instead of rhNDPK 
A in CK2 phosphorylation experiments, time-dependent inhi- 
bition of enzyme activity was also observed, reaching 30% 
inhibition after 2 h preincubation with CK2; this inhibition 
also correlated with the degree of phosphorylation of the en- 
zyme in parallel experiments. These data indicate a close re- 
lationship between the degree of phosphorylation of NDPKs 
and the inhibition of enzymatic activity. 
To assess whether phosphorylation of NDPK by CK2 af- 
fects the first step of the NDPK-catalyzed reaction, autophos- 
phorylation assays were performed with the same rhNDPK A 
aliquots that had been incubated with or without CK2 for 
different periods of time. As Fig. 1B shows, the control ex- 
periments demonstrated no differences in their autophosphor- 
ylation pattern, while there was a marked inhibition in the 
CK2-treated samples. Since compounds such as Mgzf, NaCl 
and polylysine are necessary components to accomplish phos- 
phorylation of NDPK by CK2, and since they affect the equi- 
librium of the first step of the NDPK reaction (R.M.B. and 
S.P., unpublished observations), care was taken to perform 
autophosphorylation assays with diluted samples (more than 
lOO-fold) in order to avoid any interference from these com- 
pounds. 
Taken together, these results show that the inhibition of 
NDPK enzymatic activity is due to the fact that the CK2- 
phosphorylated enzyme is probably unable to perform the 
first step of its ping-pong reaction. These results also imply 
that there is probably only one phosphorylation site per sub- 
unit. In our previous report, we showed that phosphoserine 
was the only phosphoamino acid found after acid hydrolysis 
of CK2-phosphorylated NDPK and two serine residues were 
mapped as the possible phosphorylation sites: Ser +4 and/or 
Ser +7 with respect to the histidine of the active site. Either 
residue, if phosphorylated, might affect the overall charge en- 
vironment of the active histidine, presumably altering the nec- 
essary conditions for effective nucleophilic attack on the NTP 
terminal phosphate. These Ser residues are conserved in all 
NDPKs characterized so far except Drosophila NDPK in 
which Ser +4 is replaced by Ala. Interestingly, we have shown 
that Drosophila NDPK was not phosphorylated in vitro by 
CK2 [20]. 
3.2. In vivo labeling of NDPKs from HeLa cells in culture 
To examine the possibility that serine phosphorylation 
could be a physiological means of regulation of NDPKs, 
HeLa cells were metabolically labeled with [32P]orthophos- 
phate and NDPKs were immunoprecipitated from whole ex- 
tracts. The immunoprecipitates were resuspended in buffer 
with or without Mg ‘+*TDP, the proteins being separated in 
15% SDS-PAGE and blotted onto Immobilon membranes. 
Serine/threonine phosphorylation of NDPKs was assessed 
using an improved methodology which allows reliable dis- 
crimination between histidine and serine/threonine phospho- 
rylation [19]. An autoradiograph of such an experiment is 
shown in Fig. 2. In lane 2, where the immunoprecipitated 
NDPK was not treated, two phosphorylated bands are clearly 
observed, corresponding to NDPK A and B (indicated as 
bands A and B). When a strip of the Immobilon membrane 
was treated in buffer of pH 14 (lane 4) (where His-P is stable 
C 
B 
CK2 - + 
Fig. 3. In vitro phosphorylation of rhNDPK B. Phosphorylation by 
CK2 for 1 h was performed as described 1201. The control lane . _ 
shows autophosphorylated NDPK B. Autophosphorylation was per- 
formed in the presence of 10 mM EDTA and 0.5 mM MgC12. cx in- 
dicates the position of the corresponding subunit of CK2. 
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and Ser-PIThr-P are not), the two bands corresponding to 
NDPK A and B were found to be still phosphorylated, reveal- 
ing that they were histidine phosphorylated. On the other 
hand, when another strip was treated at pH 1 (where Ser-P/ 
Thr-P are stable and His-P is not), a less intensely serinel 
threonine phosphorylated band was made visible at a position 
slightly above that of the histidine phosphorylated NDPK B 
(lane 3). This same band (labeled C) was again made visible 
when the immunoprecipitated NDPKs were incubated with 
Mg’+*TDP (lane 1); in this lane, the histidine phosphorylated 
NDPK A and B disappeared, proving that they were the 
histidine phosphorylated high-energy intermediates of the re- 
action. This third band (C) most probably represents the 
serine phosphorylated form of NDPK B; the same slight 
retardation effect on SDS gel migration was also observed 
when purified rhNDPK B was phosphorylated by CK2 in 
vitro (Fig. 3). As expected, the proximity of the two bands 
leads to a single merged band spanning B and C when blotted 
with antibodies against NDPK B (not shown). The fact that 
phosphatase inhibitor cocktails are rarely included in extract 
preparations and the proximity of the two bands in 15% 
SDS-PAGE may be reasons explaining why a third human 
NDPK band had not been previously observed using this 
methodology. In addition, in the experiment presented here, 
the intensity of band C is very minor in comparison to that of 
bands A and B and thus may be clearly visible only via a 
sensitive methodology that eliminates the background of 
band B. 
In conclusion, our demonstration of in vivo serine/threo- 
nine phosphorylation of NDPK together with the measured 
inhibitory effect of in vitro CK2 phosphorylation on NDPKs 
activity suggests that this phosphorylation could be a mechan- 
ism to regulate NDPK activity, e.g. in relation to the cell 
cycle. NDPK activity, which normally has a high turnover 
rate of up to 1000 s-l, could be partially inhibited by serine 
phosphorylation in resting cells. Upon mitogenic stimulation, 
the need for large amounts of NTPs could be satisfied rapidly 
via phosphatase-catalyzed dephosphorylation of NDPK, thus 
raising NDPK activity. 
It has been observed that NDPK expression correlates with 
proliferation in a variety of human cell models [27-291; also, 
NDPK activity correlates with proliferation of C. albicans 
yeast cells [23]. In general, de novo expression of NDPK in 
stimulated cells has been shown more clearly at the mRNA 
than at the protein level, indicating that relatively high levels 
of NDPK protein were already present in the resting cells, 
almost masking the newly synthesized protein. In the fission 
yeast Schizosaccharomyces pombe a post-translational regula- 
tion of NDPK enzymatic activity has been suggested [30]. 
Before entering the S-phase, the NDPK activity was doubled 
in step-wise fashion, without evidence of the de novo synthesis 
of NDPK protein. In this context, it would be interesting to 
know whether in vivo phosphorylation of NDPK subunits is 
cell cycle related and more abundant serine phosphorylated 
species could be detected in a particular cycle phase. It should 
be noted that HeLa cells have been a useful model to deter- 
mine the existence of serine phosphorylated NDPK, but be- 
cause cells are not synchronized, the possibility remains that 
phosphorylation represents a minority of cells at a specific 
stage of the cell cycle. 
Nevertheless, it is intriguing that only NDPK B, and only a 
fraction of the total, was found to be serine phosphorylated in 
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vivo. This fact may point to a more subtle role of phosphor- 
ylation related to its in vivo localization. In this respect, it 
should be noted that NDPK B differs from NDPK A in its 
ascribed functions and in vivo intracellular distribution. While 
both have a cytoplasmic localization, only the B isoform has 
been described as having a nuclear localization [8], correlating 
with its function as a transcription factor [13] and co-localiz- 
ing with the major population of CK2 [31]. Moreover, it re- 
mains unexplained why the NDPK B from partially purified 
from HeLa nuclear extracts, with the capacity to bind the c- 
myc promotor [ 131, eluted from a DEAE column with a great- 
er negative charge than would have been predicted from its pZ. 
Phosphorylation could indeed be responsible for this beha- 
viour. Nevertheless, one cannot rule out the possibility that 
NDPK B is in vivo phosphorylated by another kinase able to 
distinguish between the two isoforms of NDPK. 
Recently, NDPK B with a Ser + Gly mutation at position 
122 (+4) has been isolated from a malignant melanoma cell 
line [32]. This mutation has no influence on the enzyme activ- 
ity; however, based on the results presented here, the hypoth- 
esis may be raised that the Ser + Gly 122 mutation may affect 
NDPK regulation through phosphorylation. Hence, removal 
of an inhibitory phosphorylation site in NDPK might also be 
important for tumorigenesis in some cases. 
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